AIMA
MRK icon

Ables Iannone Moore & Associates’s Merck MRK Stock Holding History

Ables Iannone Moore & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-515
Closed -$56.1K – 203
2023
Q4 		$56.1K Buy
+515
New +$53.5K 0.04% 89

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ables Iannone Moore & Associates's MRK Position: Q1 2024 in Review

Ables Iannone Moore & Associates sold out of Merck (MRK) in Q1 2024, closing a stake of 515 shares — an estimated $56.1K sold.

Ables Iannone Moore & Associates first reported a position in MRK in Q4 2023 and held it in 1 quarter. The position peaked at $56.1K in Q4 2023. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Ables Iannone Moore & Associates reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • Ables Iannone Moore & Associates sold 515 Merck shares in Q1 2024, an estimated $56.1K.
  • Ables Iannone Moore & Associates first reported a position in Merck in Q4 2023 and held it in 1 quarter.
  • Ables Iannone Moore & Associates's Merck position peaked at $56.1K in Q4 2023.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Ables Iannone Moore & Associates's 13F filing for Q1 2024, filed 30 Apr 2024.